Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis

Background: Age-related macular degeneration (AMD) is the leading cause of vision loss in elderly people. Current pharmacological treatment in vascular AMD includes anti-VEGF agents, such as ranibizumab and aflibercept. Additionally, the off-label use of bevacizumab has been shown to be effective an...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Pharmaceuticals
المؤلفون الرئيسيون:	João Estarreja, Priscila Mendes, Carina Silva, Pedro Camacho, Vanessa Mateus
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2024-07-01
الموضوعات:	AMD age-related macular degeneration bevacizumab drug therapy nAMD neovascular age-related macular degeneration
الوصول للمادة أونلاين:	https://www.mdpi.com/1424-8247/17/8/1000